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Abstract
Background: There are no specific treatments for the neurological alterations of cirrhotic patients with minimal
hepatic encephalopathy (MHE). Rats with MHE due to portacaval shunt (PCS) show impaired spatial learning. The
underlying mechanisms remain unknown. The aims of this work were to assess: (a) whether PCS rats show
neuroinflammation in hippocampus, (b) whether treatment with sildenafil reduces neuroinflammation and
restores spatial learning in PCS rats, and (c) analyze the underlying mechanisms.
Methods: Neuroinflammation was assessed by determining inflammatory markers by Western blot. Phosphorylation
of MAP-kinase p38 was assessed by immunohistochemistry. Membrane expression of GABA and glutamate receptors
was analyzed using BS3 cross-linker. Spatial learning was analyzed using the radial and Morris water mazes. To assess if
sildenafil reverses the alterations, rats were treated with sildenafil in the drinking water.
Results: PCS rats show increased IL-1β and TNF-α levels and phosphorylation (activity) of p38 in hippocampus.
Membrane expression of subunits α1 of GABAA receptor and GluR2 of AMPA receptor are increased in PCS
rats, while subunits GluR1 of AMPA receptors and NR1 and NR2a of NMDA receptors are reduced. PCS rats
show reduced spatial learning in the radial and Morris water mazes. Sildenafil treatment normalizes IL-1β and
TNF-α levels, p38 phosphorylation, and membrane expression of GABAA, AMPA, and NMDA receptors and restores
spatial learning.
Conclusions: Increased IL-1β alters GABAergic and glutamatergic neurotransmission in hippocampus and impairs
spatial learning in rats with MHE. Sildenafil reduces neuroinflammation and restores learning. Phosphodiesterase-5
inhibitors may be useful to improve cognitive function in patients with MHE.
Keywords: cGMP, Neuroinflammation, Hepatic encephalopathy, Cognitive impairment, Sildenafil treatment
Background
Minimal hepatic encephalopathy (MHE) is not clinically
evident but can be unveiled using psychometric tests.
MHE is suffered by around 40 % of cirrhotic patients
(several million people). Patients with MHE show psy-
chomotor slowing, attention deficits, mild cognitive im-
pairment, and visuo-spatial incoordination [1]. These
deficits affect their quality of life, progresses to clinical
HE, and reduces life span.
Hyperammonemia and inflammation act synergistic-
ally to induce mild cognitive and motor impairment in
MHE [2–4]. Chronic hyperammonemia per se induces
neuroinflammation that contributes to the neurological
alterations in MHE [5]. The mechanisms responsible for
some specific neurological alterations in MHE are begin-
ning to be clarified in animal models [6–8].
Rats with portacaval shunts (PCS) are a good model
of MHE that reproduces cognitive and motor alter-
ations present in patients with MHE [9]. In PCS rats,
neuroinflammation in cerebellum mediates the impair-
ment in the ability to learn a Y-maze task [10] and in
basal ganglia mediates hypokinesia [11]. Different types
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of cognitive functions and of learning or memory are
modulated by different mechanisms involving different
pathways and brain areas. While the ability to learn a
Y-maze task is mainly modulated in cerebellum by the
glutamate-NO-cGMP pathway, spatial learning, and
memory are mainly modulated in hippocampus by dif-
ferent mechanisms. Therefore, restoring spatial learning
and memory requires normalizing these mechanisms in
hippocampus. Spatial learning in the Morris water
maze is impaired in PCS rats [12] but the underlying
mechanisms and the role of neuroinflammation have
not been studied in detail.
We hypothesize that these mechanisms could be me-
diated by increased interleukin 1β (IL-1β) in hippocam-
pus. Sustained expression of IL-1β in hippocampus
impairs spatial learning and memory [13]. Wang et al.
[14] showed that IL-1β, through activation of p38
mitogen-activated protein kinase, leads to enhanced
membrane expression of GABAA receptors and of an
associated inhibitory current in hippocampus and im-
paired learning. Blocking GABAA receptors prevented
the impairment of learning induced by IL-1β.
The above studies suggest that impaired spatial learn-
ing in PCS rats could be due to neuroinflammation in
hippocampus and that reducing it could restore spatial
learning.
The phosphodiesterase-5 inhibitor sildenafil reduces
neuroinflammation in hippocampus and improves cog-
nitive performance in APP/PS1 transgenic mice model
of Alzheimer’s disease [15]. Sildenafil also reduces neu-
roinflammation and IL-1β levels in cerebellum in an in-
flammatory model of demyelination in mice [16] and
restores learning of a Y-maze conditional task, mainly
modulated in cerebellum, in PCS rats [17]. It has not
been assessed whether sildenafil reduces neuroinflam-
mation and/or improves spatial learning in rats with
MHE due to PCS.
The aims of this work were the following:
a) assess whether PCS rats show neuroinflammation in
hippocampus;
b) assess whether treatment with sildenafil reduces
hippocampal neuroinflammation and restores
spatial learning in PCS rats, and
c) analyze the underlying mechanisms, including
changes in membrane expression of glutamate and
GABAA receptors.
Methods
Portacaval anastomosis and treatment with sildenafil
Male Wistar rats (220–240 g) subjected to end-to side
portacaval anastomosis as described by Lee and Fisher
[18]. Control rats were sham operated. Adequate mea-
sures were taken to minimize pain and discomfort to the
animals. The experiments were approved by the Comite
de Experimentación y Bienestar Animal (CEBA) of our
center and performed in accordance with guidelines of
the Directive of the European Commission (2010/63/
EU) for care and management of experimental animals.
Rats were treated with sildenafil (50 mg/L, purified
from Viagra pills) in the drinking water, beginning
4 weeks after PCS surgery until sacrificed. The experi-
mental design is summarized in Fig. 1.
Analysis of protein content in hippocampus by
Western blot
Homogenates of hippocampus were subjected to im-
munoblotting as in [19]. Primary antibodies were against
IL-4, IL-10 (1:2000) α1 and α5 subunits of GABAA re-
ceptors (1:500) from Abcam (Cambridge, UK); IL-1β
and TNF-α (1:500) from R&D SYSTEMS (Minneapolis,
USA); GluR1(1:1000) from Calbiochem (Darmstadt,
Germany); GluR2 (1:1000) from Chemicon (Temecula,
CA, USA); NR1 (1:1000) from BD Biosciences (San Jose,
CA, USA), and NR2A (1:1000) from Upstate Biotechnol-
ogy (New York, NY, USA). As control for protein load-
ing, the membranes were incubated with anti-actin
(Abcam, Cambridge, MA; 1:1000). Secondary antibodies
were anti-rabbit, anti-goat, or anti-mouse IgG (1:2000)
conjugated with alkaline phosphatase (Sigma, St. Louis,
MO). The images were captured using the ScanJet
5300C (Hewlett-Packard, Amsterdam, Netherlands) and
band intensities quantified using the Alpha Imager 2200,
version 3.1.2 (AlphaInnotech Corporation, San Francisco).
Analysis of surface expression of receptors by cross-
linking with BS3 was performed as described in [20].
Hippocampi were dissected and transversal slices (400 μm)
were obtained using a chopper. Slices were added to tubes
Fig. 1 Scheme showing the experimental design
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containing ice-cold standard buffer with or without 2 mM
BS3 (Pierce, Rockford, IL) and incubated for 30 min at
4 °C. Cross-linking was terminated by adding 100 mM
glycine (10 min, 4 °C). The slices were homogenized by
sonicating for 20 s. Samples treated or not with BS3 were
analyzed by Western blot. The surface expression of each
receptor was calculated as the difference between the in-
tensity of the bands without BS3 (total protein) and with
BS3 (non-membrane protein).
Spatial learning
Spatial learning in the Morris water maze. The test was
carried out as described in [12]. After pre-training, rats
were trained to learn the fixed location of the hidden
platform during 4 days (three swims per day). Rats were
allowed a maximum of 120 s to find the platform. The
time needed to find the platform was recorded as a
measure of learning.
Spatial learning in the 8-arms radial maze was
assessed as described in [21]. Training was performed
during 10 days (three trials per day). The number of
working memory errors (working errors, visits to
arms already visited in the same trial) were recorded
and are presented in blocks of 2 days.
Immunohistochemistry
Immunohistochemistry was performed as described in [5].
Five to six animals per group were anesthetized and trans-
cardially perfused with 150 mL of saline, followed by
250 mL of 0.4 % paraformaldehyde in 0.1 M phosphate
buffer pH 7.4. Brains were removed and immersed for
24 h at 4 °C in the same fixative. Free-floating sections
(30 μm) were cut through the hippocampus. For the DAB
sections, sections were incubated with biotinylated sec-
ondary antibodies and avidin-biotin-HRP complex (ABC
kit, Vector, CA, USA) followed DAB-H2O2 substrate. For
immunofluorescence, sections were incubated with the
corresponding fluorescent secondary antibody followed by
incubation with the nuclear marker DAPI. The stained
sections were mounted on slides and coverslipped.
Primary antibodies used were the same as for West-
ern blot but with (1:200) dilutions for IL-1β, receptor
of IL1β, p38-MAPK from Millipore (Darmstadt,
Germany). The secondary biotinylated antibodies
(1:200) from Vector Laboratories (Burlingame, CA,
USA) and secondary fluorescent antibodies (1:500)
from Invitrogen (Oregon, USA) were used.
Analysis of microglial activation
Microglial activation was assessed in the CA1 region
of hippocampus by immunohistochemistry as in [22].
Microglia was stained with anti-Iba 1 (1:200) as above
and the total perimeter of individual microglial cells
was measured using Image J software (ImageJ 1.48v,
http://imagej.nih.gov/ij) by counting the number of
pixels surrounding the cell. Eight sections per rat
were analyzed in three rats per group and the mean
perimeter of microglial cells was calculated.
Phosphorylation of MAP kinase p38 in hippocampus
was assessed by immunohistochemistry as described
above using an antibody against phosphorylated p38
(1:200) from Millipore (Darmstadt, Germany). This ap-
proach was chosen because sacrifice of rats and hippo-
campus homogenization alters p38 phosphorylation.
Rats were perfused transcardially with 0.4 % parafor-
maldehyde that fixes the tissue and preserves p38 phos-
phorylation as present in vivo.
Statistical analysis
The results are presented as mean ± standard error of
mean (SEM). The data were analyzed by one-way
ANOVA followed Dunnett’s T test. p values lower than
0.05 were considered statistically significant. Statistical
analysis was performed using the Graph Pad Prism 4
software (GraphPad Software Inc. San Diego, CA).
Results
PCS rats show increased levels of IL-1β, TNF-α and
phosphorylation of p38 in hippocampus, which are
reversed by sildenafil
The content of IL-1β in hippocampus, as analyzed by
Western blot (Fig. 2a), was increased in PCS com-
pared to control rats (149 ± 19 %, p < 0.05). Treatment
with sildenafil did not affect IL-1β in control rats
(108 ± 10 %) but reduces it to normal levels in PCS
rats (88 ± 12 %, p < 0.05).
A similar effect was observed for TNF-α and for
IL-10, while IL-4 is not significantly affected in PCS
rats or by sildenafil (Table 1).
The content of the receptor for IL-1β is slightly but
not significantly increased in PCS rats (122 ± 15 %) and
was not affected by sildenafil in control or PCS rats
(Fig. 2b).
Both IL-1β (Fig. 2c, d) and its receptor (Fig. 2e, f ) are
present in neurons of the CA1 region of hippocampus,
as revealed by immunohistochemistry.
To assess whether reduction of IL-1β levels by silden-
afil in PCS rats is associated with reduced microglial
activation, we analyzed it by immunohistochemistry.
PCS rats show a mild activation of microglia in hippo-
campus which is reflected in a reduction of the perim-
eter which was 3336 ± 225 pixels in control rats and
was reduced (p < 0.05) in PCS rats to 2481 ± 211. In
PCS rats treated with sildenafil, the perimeter returned
to normal values (2972 ± 596 pixels), indicating that it
reduces microglial activation in PCS rats (Fig. 3).
Phosphorylation of p38, as analyzed by immunohisto-
chemistry was increased in the CA1 region of
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hippocampus of PCS compared to control rats. Treat-
ment with sildenafil strongly reduced the phosphoryl-
ation of p38 both in control and PCS rats (Fig. 4a).
Figure 4b shows by double fluorescence staining that
phosphorylation of p38 is mainly located in neurons and
is very low in neurons of CA1 region of hippocampus in
control rats, is strongly increased in PCS rats and is re-
duced by treatment with sildenafil.
Membrane expression of GABAA and GluR2 receptors is
increased and that of NR1, NR2A, and GluR1 are reduced
in hippocampus of PCS rats. All these changes are reversed
by sildenafil
Membrane expression of different GABAA and glutam-
ate receptor subunits in hippocampus was quantified
using the BS3 method.
The expression in membrane of the alpha 1 subunit
of GABAA receptors was increased in PCS rats to
166 ± 19 % (p < 0.05) of controls while that of the
alpha 5 subunit was not affected (Fig. 5a, b).
Concerning NMDA receptors, both the membrane
expression of NR1 and NR2A subunits were reduced
(p < 0.05) in PCS rats to 53 ± 15 and 54 ± 13 % of
controls, respectively (Fig. 5c, d).
Concerning AMPA receptors, the membrane expres-
sion of the GluR1 subunit was reduced (p < 0.05) in PCS
rats to 56 ± 1 % while the expression of the GluR2 sub-
unit was strongly increased to 227 ± 60 % of controls
(Fig. 5e, f ).
Treatment with sildenafil normalized the membrane ex-
pression of all the subunits altered in PCS rats: alpha 1 of
GABAA receptors, NR1 and NR2A of NMDA receptors,
and GluR1 and GluR2 of AMPA receptors (Fig. 5a–f ).
It is noteworthy that changes in the above subunits in
PCS rats are specific for membrane expression, while
Table 1 IL-1β, TNF-α, and IL-10 contents are increased in
hippocampus of PCS rats and are normalized by treatment
with sildenafil
Hippocampus Sham Sham + SILD PCS PCS + SILD
TNF-α 100 ± 17 125 ± 13 144 ± 9* 103 ± 7aa
n = 9 n = 10 n = 9 n = 9
IL-1β 100 ± 7 108 ± 10 149 ± 19* 88 ± 12a
n = 12 n = 13 n = 12 n = 12
IL-4 100 ± 9 109 ± 14 112 ± 12 93 ± 13
n = 10 n = 10 n = 10 n = 11
IL-10 100 ± 11 106 ± 7 144 ± 13* 105 ± 10a
n = 11 n = 11 n = 10 n = 10
Values are the mean ± SEM of the number of rats indicated (n). Values
significantly different from sham rats are indicated by asterisks. Values
significantly different from PCS rats not treated with sildenafil are
indicated by a
*p < 0.05; ap < 0.05; aap < 0.01
Fig. 2 IL1β levels are increased in hippocampus of PCS rats and are normalized by treatment with sildenafil. IL1β (a) and IL1β receptor
(b) amount in the hippocampus were determined by Western blot in sham and PCS treated with saline or sildenafil (SILD). Representative
images of the Western blots are shown. Values are the mean ± SEM of 12 rats per group. c–f Confocal images showing the expression of
IL-1β and IL-1 receptor in neurons of the CA1 region of hippocampus of PCS rats. c, d IL1β signal (red), nucleus marker DAPI (blue), and
neuronal marker Neun (green). Note the expression of IL1β in the CA1 region both in neurons (arrow heads) and no neuronal cells (arrows). e, f IL1β
receptor signal (red) and Neun (green). Note the expression of the IL1β receptor in the pyramidal CA1 neurons. Scale bar 10 μm (c, d) and 20 μm (e, f)
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the changes in total amount of each subunit in the
whole hippocampus homogenate were different: alpha 1
and NR1 subunits are slightly increased, NR2A and
GluR2 are not affected while GluR1 is reduced (Fig. 6).
Spatial learning is impaired in PCS rats and is restored by
sildenafil
PCS rats show reduced learning ability in the Morris
water maze. As shown in Fig. 7a, all groups of rats
learned to find the platform and the latency to reach
it was reduced along the four training days. However,
learning ability was significantly reduced in PCS rats
(p < 0.05 versus controls). The latency to find the
platform on day 3 is shown in Fig. 7b. Control rats
needed 34 ± 5 s to find the platform, while PCS rats
needed more time (51 ± 5 s, p < 0.01).
Treatment with sildenafil completely restored spatial
learning in the Morris water maze in PCS rats. As
shown in Fig. 7a, learning ability of PCS rats treated
with sildenafil was identical to control rats. On day 3,
PCS rats treated with sildenafil needed 26 ± 4 s to
find the platform, which was not different from con-
trol rats and was significantly lower (p < 0.01) than
for PCS rats (Fig. 7b).
We also assessed spatial learning in the radial maze.
As shown in Fig. 8, PCS rats show reduced spatial
Fig. 3 Microglia is activated in hippocampus of PCS rats. Sildenafil reduces microglial activation. a. Microglial activation was analyzed in the CA1
region of hippocampus by measuring the perimeter of microglial cells stained with Iba-1. Values are given as number of pixels surrounding
microglial cells. Values are the mean ± SEM of eight sections per rats and three rats per group. Representative images of microglia morphology
as stained with Iba-1 are shown for sham controls (b), sham control rats treated with sildenafil (c), PCS rats (d) and PCS rats treated with sildenafil (e).
Scale bar (b–e) =10 μm
Fig. 4 Phosphorylation of p38 is increased in hippocampus of PCS rats and is normalized by treatment with sildenafil. a, b Representative
images of phosphorylated p38 (P-p38) in the CA1 region of the dorsal hippocampus in control and PCS rats, treated with vehicle or sildenafil
(SIL). a Phosphorylated p38 immunostained with DAB. Note the higher intensity in PCS rats. b Confocal images of the immunostaining for
Neun (green) and phosphorylated p38 (red) in neurons of the CA1 region. Scale bar 100 μm in (a) and 20 μm in (b)
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learning, with more working errors than controls at all
blocks. Treatment with sildenafil progressively reduced
the working errors in PCS rats and completely restored
spatial learning at blocks 4 and 5 (Fig. 8). Working
Fig. 5 Surface receptor expression was assessed in SHAM and PCS treated or not with sildenafil (SILD). The membrane expression of the alpha 1
subunit of GABAA receptor (A-B), NR1 and NR2a subunits of NMDA receptors (C-D) and GluR1 and GluR2 subunits of AMPA receptors (E-F) is
altered in hippocampus of PCS rats and is normalized by treatment with sildenafil. Membrane expression of each subunit in hippocampus was
analyzed using the BS3 crosslinker procedure as described in methods. Samples incubated in the absence or presence of BS3 were subjected to
Western blotting using antibodies for each of the subunits. BS3 or sildenafil presence or absence was expressed as “+” or “-“, respectively.
Representative images are shown. Samples in the absence of BS3 represent the total amount of each protein. Samples in the presence of BS3
represent the non-membrane fraction. The intensities of the bands were quantified and membrane expression was calculated as the difference of
intensity between samples without and with BS3. Values are expressed as percentage of control rats and are the mean ± standard errors of 14–18 rats
per group. Values significantly different from control rats are indicated by asterisks and from PCS rats by “a”. *p < 0.05;**p < 0.01; ap < 0.05
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errors in block 4 of tests were 5.8 ± 1.1 in sham rats and
were not different (6.3 ± 1.4) in sham rats treated with
sildenafil. The number of working errors was in-
creased (p < 0.05) in PCS rats to 12.7 ± 1.9 and was
completely normalized in PCS rats treated with sil-
denafil (6.6 ± 2.3). Similar findings were obtained for
block 5 of tests (Fig. 8).
Discussion
The results reported show that rats with MHE due to
PCS have neuroinflammation and microglial activation
in hippocampus, with increased levels of IL-1β and
TNF-α. This is associated with:
1. A strong alteration in membrane expression
of GABAA, AMPA, and NMDA receptors which
would result in altered neurotransmission and
2. Impaired spatial learning in the radial and Morris
water mazes.
Treatment with sildenafil normalizes microglial acti-
vation and the levels of IL-1β and TNF-α in hippo-
campus, which is associated with normalization of
Fig. 6 Total receptor expression was assessed in SHAM and PCS treated or not with sildenafil (SILD). Total amount of the alpha 1 subunit of GABAA
receptor (A-B), NR1 and NR2a subunits of NMDA receptors (C-D) and GluR1 and GluR2 subunits of AMPA receptors (E-F) in hippocampus of PCS and
SHAM rats treated or not with sildenafil. Experiments were the same shown in Fig. 5 but only the samples incubated in the absence of BS3 (total
amount) are presented. The intensities of the bands were quantified and expressed as percentage of control rats. Values are the mean ± standard
errors of 14–18 rats per group. Values significantly different from control rats are indicated by asterisks and from PCS rats by a. *p < 0.05; ap < 0.05;
aaap < 0.001
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membrane expression of glutamate and GABA recep-
tors and of spatial learning ability in the radial and
Morris water mazes.
The alterations found in hippocampus of PCS rats are
summarized in Fig. 9. Increased levels of IL-1β lead to
over-activation of IL-1 receptor which would enhance
phosphorylation and activity of MAP-kinase p38 and
lead to increased membrane expression of the alpha 1
subunit of GABAA receptors. The membrane expression
of the GluR2 subunit of AMPA receptors is also strongly
increased in hippocampus of PCS rats, while those of
the GluR1 subunit and of the NMDA receptor subunits,
NR1 and NR2a are reduced. These data suggest that
neuroinflammation, and particularly increased levels of
IL-1β in hippocampus would lead to strong alterations
in GABAergic and glutamatergic neurotransmission in
hippocampus which would be responsible for the im-
pairment of spatial learning in rats with MHE.
It has already been shown that increased levels of
IL-1β in hippocampus impair spatial learning and mem-
ory in different situations. Transgenic mice overexpressing
human IL-1β in hippocampus show increased IL-1β and
neuroinflammation in hippocampus and impaired spatial
memory in the Morris water maze [13, 23]. Other situa-
tions which increase IL-1β in the hippocampus also result
in impaired spatial learning and memory. This occurs for
example in post-operative cognitive dysfunction. Surgery
of the tibia under general anesthesia in mice caused hip-
pocampal-dependent memory impairment that was as-
sociated with increased IL-1 β in the hippocampus.
Functional inhibition of IL-1β, both in mice pretreated
with IL-1 receptor antagonist and in mice lacking IL-1
receptor, reduced memory dysfunction [24].
Increased levels of IL-1β in hippocampus also mediate
the spatial memory deficits in rats injected with the ba-
cillus Calmette-Guérin (BCG) in the hippocampus,
which were abrogated by the natural antagonist of IL-1
receptors, IL-1Ra [25]. Increased IL-1β in hippocampus
also mediates cognitive impairment following injection
of lipopolysaccharide to mimic systemic infection [26] or
isoflurane exposure to mimic anesthetic-related cogni-
tive dysfunction in aging [27].
The data in the above reports support that the in-
creased levels of IL-1β found in hippocampus of rats
with MHE due to PCS are enough to explain their im-
pairment of spatial learning in the radial and Morris
water mazes. Also, the restoration of learning ability of
PCS rats by sildenafil would be due to the normalization
of IL-1β levels in hippocampus.
A main mechanism by which over-activation of IL-1β
receptors in hippocampus led to cognitive impairment
is by enhancing GABAergic neurotransmission. Hellstrom
et al. [28] showed that in hippocampal slices, lipopoly-
saccharide increases IL-1β levels and GABAergic neuro-
transmission. Co-incubation with the IL-1 receptor
antagonist, IL-1Ra prevented the LPS-induced enhance-
ment of GABAergic potentials, indicating that IL-1β
Fig. 8 Spatial learning in the radial maze is impaired in PCS rats and
is restored by treatment with sildenafil. Spatial learning ability in the
radial maze was assessed in sham and PCS rats, treated with vehicle
or sildenafil (SIL). Values are the mean ± SEM of 10–14 rats per
group. Values significantly different from control rats are indicated by
asterisks and from PCS rats by a. *p <0.05; ap < 0.05
Fig. 7 Spatial learning in the Morris water maze is impaired in PCS rats and is restored by treatment with sildenafil. Spatial learning ability in the
Morris water maze was assessed in sham and PCS rats, treated with vehicle or sildenafil (SIL). a Escape latencies (in seconds) to reach the platform
during the different sessions. b Escape latencies (in seconds) in the third session. Values are the mean ± SEM of 15–18 rats per group.
Values significantly different from control rats are indicated by asterisks and from PCS rats by a. *p < 0.05; ap < 0.05; aap < 0.01
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enhances GABAergic transmission. This enhancement
seems to be mainly due to IL-1β-induced increased
membrane expression of GABAA receptors. IL-1β en-
hances GABAA receptor cell-surface expression and
GABA-elicited chloride currents by a phosphatidylinositol
3-kinase/Akt pathway in hippocampal neurons [29].
Wang et al. [14] showed that IL-1β, through activa-
tion of p38 mitogen-activated protein kinase, leads to
enhanced membrane expression of GABAA receptors
and of an associated inhibitory current leading to re-
duced learning ability. Blocking GABAA receptors
prevented the impairment of LTP and of learning in-
duced by IL-1β.
We have also found that the membrane expression of
GABAA receptor subunit alpha 1 is increased in hippo-
campus of PCS rats, which could be mediated by the
increased activity (phosphorylation) of MAP-kinase
p38. This would enhance GABAergic neurotransmis-
sion and contribute to the impairment of spatial learn-
ing in rats with MHE due to PCS. Treatment of PCS
rats with sildenafil completely normalized membrane
expression of GABAA receptor, returning to levels simi-
lar to those of control rats. This would be a conse-
quence of normalization of IL-1β levels by sildenafil
and would contribute to the sildenafil-induced restor-
ation of spatial learning in PCS rats.
As shown in Fig. 5, in addition to the increased mem-
brane expression of the alpha 1 subunit of GABAA re-
ceptors, rats with MHE due to PCS also show strong
alterations in the membrane expression of NMDA and
AMPA receptors, with reduced expression of the NR1
and NR2a subunits of NMDA receptors and of the
Fig. 9 Proposed model for the mechanisms involved in impairment of spatial learning and memory in rats with HE and for their improvement by
sildenafil, in hippocampal neuron (CA1) membrane. (A) PCS rats show neuroinflammation with increased (red arrow) levels of IL-1β. Over-
activation of IL-1 receptor by IL-1β is associated with increased phosphorylation and activity of p38 and increased membrane expression of the
alpha 1 subunit of GABAA receptors. The membrane expression of the GluR2 subunit of AMPA receptors is also increased while surface expression
of the GluR1 subunit of AMPA receptors and of NR1 and NR2a subunits of NMDA receptors is reduced. (B) Treatment with sildenafil reverses
(red arrow with green circles) all these changes, returning to values similar to control rats
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GluR1 subunit of AMPA receptors and increased ex-
pression of the GluR2 subunit of AMPA receptors.
These alterations are not due to parallel changes in the
amount of the receptors (see Figs. 5, 6), but to altered
modulation of membrane expression, likely through
changes in phosphorylation.
The reduced membrane expression of GluR1 would
be also a consequence of increased IL-1β. Lai et al. [30]
showed that exposure to IL-1β reduces phosphorylation
in Ser831 and membrane expression of GluR1 in hippo-
campal neurons, and this was prevented by IL-1Ra, an
antagonist of IL-1 receptors. Interestingly, it seems that
changes in GluR1 membrane expression would be me-
diated by NMDA receptors. Blocking these receptors
with APV prevented IL-1β-induced downregulation of
GluR1 surface expression [30].
As NMDA and AMPA receptors play key roles in LTP
and learning, their alterations in PCS rats would also
contribute to the impairment of spatial learning in the
radial and Morris water maze. The two-fold increase in
membrane expression of GluR2 together with the reduc-
tion of GluR1 by 44 % leads to a strong increase in the
ratio of GluR2/GluR1 subunits of AMPA receptors in
the membrane in hippocampus of PCS rats. This would
have important consequences on the function of AMPA
receptors. Activation of AMPA receptors allows the
entry of Na+. Receptors lacking GluR2 subunits are also
permeable to Ca2+ [31]. The presence of a single GluR2
subunit is enough to maximally reduce Ca2+ permeabil-
ity [32]. The strong increase of GluR2 subunits in the
membrane of PCS rats will strongly reduce Ca2+ entry
through AMPA receptors. The reduced amount of
NMDA receptors in the membrane will also reduce Ca2+
entry in PCS rats through these receptors.
These data suggest that the release of glutamate in
the synapsis of PCS rats will lead to much lower in-
creases in Ca2+ in the post-synaptic neurons than in
control rats due to reduced entry through both NMDA
and AMPA receptors. This would lead to strong alter-
ations in the activation of associated signal transduction
pathways in PCS rats, which would contribute to impair
learning ability.
Normalization of NMDA and AMPA receptors by
sildenafil treatment would contribute to restore signal
transduction and learning ability.
Sildenafil normalizes IL-1β levels in hippocampus,
membrane expression of all receptors and spatial learn-
ing in the radial and Morris water mazes. This indicates
that it could be a good therapeutic tool to reduce neuro-
inflammation and improve cognitive function in MHE.
The mechanisms by which sildenafil reduces neuroin-
flammation would involve cGMP increase and activa-
tion of cGMP-dependent protein kinase (PKG). Zhang
et al. [15] have shown that transgenic Tg APP/PS1
mice, a model for Alzheimer’s disease, show increased
levels of IL-1β in hippocampus and cognitive impair-
ment. Treatment with sildenafil reduces IL-1β to nor-
mal levels and restores cognitive function. Both effects
are prevented by an inhibitor of PKG, indicating that
activation of PKG by cGMP mediates the effects of sil-
denafil on neuroinflammation and cognitive function.
Zhang et al. [15] propose that phosphorylation of CREB
by PKG is reduced in Tg mice and its recovery by sil-
denafil treatment mediates the reduction of IL-1β levels.
The modulation of IL-1β levels by sildenafil may
occur at the level of transcription or translation. cGMP
modulates directly, through phosphorylation by PKG,
the activity of several transcription factors including
CREB, ATF-1, TFII-I, and NF-kB [32]. Both positive
and negative effects of cGMP have been described for
expression of genes for inflammatory proteins (iNOS,
COX-2, and TNF-a), leading in some cases to biphasic
regulation. Moreover, cGMP may also modulate gene
expression post-transcriptionally, by regulating mRNA
stability. Elevated levels of cGMP may lead to mRNA
destabilization due to downregulation of the mRNA
stabilizing factor HuR [33].
IL-1β transcription is mainly modulated by NF-kB
[34]. cGMP may enhance activation of NF-kB through a
noncanonical pathway involving phosphorylation of
NF-kB proteins by PKG [35]. However, cGMP may also
reduce activation of NF-kB [36] by a mechanism involv-
ing cGMP-mediated activation of heat shock transcrip-
tion factor (HSF), resulting in elevated HSP70 protein
and enhanced binding of HSP70 to IkB, the natural in-
hibitor of NF-kB translocation to the nucleus and acti-
vation [37]. Sildenafil would reduce IL-1β levels by
increasing cGMP which may reduce transcriptional ac-
tivity of NF-kB or IL-1β mRNA stability by mechanisms
like those discussed above.
The results reported also support that different
types of cognitive alterations in rats with MHE are
due to different mechanisms involving different path-
ways and brain areas and may require different treat-
ments. Impairment of the ability to learn a Y-maze
task is mainly due to the reduced function of the
glutamate-NO-cGMP pathway in cerebellum, and may
be restored by normalizing the function of this path-
way [8]. In contrast, impairment of spatial learning
and memory is mainly due to the increased levels of
IL-1β in hippocampus, leading to altered membrane
expression of GABAA, AMPA, and NMDA receptors
and may be restored by reducing IL-1β levels. This
can be achieved using inhibitors of phosphodiesterase
5 such as sildenafil.
These results suggest that inhibitors of phospho-
diesterase 5 may be useful to improve cognitive func-
tion in cirrhotic patients with MHE. Wang et al. [38]
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suggest that sildenafil may exacerbate portal hyperten-
sion and hyperdynamic circulation in patients with ad-
vanced cirrhosis and porto-pulmonary hypertension.
However, inhibitors of phosphodiesterase 5 are being
used to treat erectile dysfunction in many cirrhotic pa-
tients who have not shown secondary effects. Moreover,
these inhibitors are also now being used for treatment
of pulmonary hypertension and benign hyperplasia of
prostate for which new formulations for chronic use
have been developed which would be more appropri-
ate to improve cognitive function in cirrhotic patients
with MHE without secondary effects.
Conclusions
The results reported show that rats with MHE due to
PCS show neuroinflammation in hippocampus, with in-
creased levels of IL-1β and activity of MAP-kinase p38,
which are associated with a strong alteration in the
membrane expression of GABAA, AMPA, and NMDA
receptors and impairment of spatial learning in the ra-
dial and Morris water mazes. Treatment with sildenafil
normalizes IL-1β levels, phosphorylation of p38 and
membrane expression of GABAA, AMPA, and NMDA
receptors and restores spatial learning ability.
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